Reaxa showcases Ni EnCat technology

By Phil Taylor

26-Nov-2008 - Last updated on 28-Sep-2021 at 09:13 GMT

Reaxa CEO Dr Peter Jackson explains why the firm added a nickel catalyst to its EnCat range.

Related news

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

HEALTH IS A JOINT PROJECT READY FOR NEXT-GENERATION CDMO

Content provided by Indena | 15-Mar-2023 | White Paper

Indena offers custom development by leveraging the expertise of a specialized team devoted to designing and developing processes and analytical methods....

Reaxa showcases Ni EnCat technology

Related news

Related products

Efficient Freezing & Storage of Biopharmaceuticals

HEALTH IS A JOINT PROJECT READY FOR NEXT-GENERATION CDMO

Follow us

Products

Webinars

Headlines

Promotional Features

Outsourcing-Pharma

Resources